Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia in the treatment of advanced ovarian cancer

about

Increase of Incidence and Mortality of Ovarian Cancer during 2003-2012 in Jiangsu Province, China.

P2860

Q37072207-6D57DCA9-C114-49E7-9E0B-9484DA149C53

P2860

Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia in the treatment of advanced ovarian cancer

Item

http://www.wikidata.org/entity/Q40490536

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Docetaxel combined with intrap ...... ent of advanced ovarian cancer

@en

type

Item

label

Docetaxel combined with intrap ...... ent of advanced ovarian cancer

@en

prefLabel

Docetaxel combined with intrap ...... ent of advanced ovarian cancer

@en

P1476

Docetaxel combined with intrap ...... ent of advanced ovarian cancer

@en

P2093

Lijie Li

http://www.w3.org/2001/XMLSchema#string

Min Xue

http://www.w3.org/2001/XMLSchema#string

Qiong Pan

http://www.w3.org/2001/XMLSchema#string

Songshu Xiao

http://www.w3.org/2001/XMLSchema#string

Ting Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The C3G/Rap1 pathway promotes secretion of MMP-2 and MMP-9 and is involved in serous ovarian cancer metastasis.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.

Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approach.

Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study

Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasms

Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature.

Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy.

Current status and future directions of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer.

Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer.

Thioredoxin 1 upregulates FOXO1 transcriptional activity in drug resistance in ovarian cancer cells.

P304

3287-3292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.4414

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27123104

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

4840847

http://www.w3.org/2001/XMLSchema#string

Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia in the treatment of advanced ovarian cancer

about

P2860

P2860

Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia in the treatment of advanced ovarian cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932